DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Chronic Kidney Disease (CKD) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report to their offering.
The global Chronic Kidney Disease (CKD) Drugs market was valued at US$ 12.4 Bn in 2016, and is expected to reach US$ 17.4 Bn by 2025, expanding at a CAGR of 3.9% from 2017 to 2025.
Chronic Kidney Disease (CKD) is also known as chronic kidney failure, characterized by gradual loss of kidney function. There are different types of medications available in market. Medicines cannot reverse CKD; however, they are used to treat complications and to slow further kidney damage. Factors such as rising incidence of cardiovascular disorders and diabetes, increasing geriatric population, significant unmet needs, promising pipeline molecules such as ABT-614 (Abbott Laboratories) and EOS789 (Chugai Pharmaceutical) and increasing prevalence of CKD would further drive the growth of CKD drugs market globally. However, preferable use of generic drugs and in some countries may negatively impacting the market growth.
Currently, CKD drugs market is dominated by North America, due to factors such as higher cost of medication, changing healthcare reimbursement environment and upsurge in funding by government agencies and private organizations in healthcare system driving the growth of CKD drugs market in North America.
- Abbvie, Inc
- Allergan Plc
- Amgen Inc
- Astrazeneca Plc
- F. Hoffmann-La Roche Ltd
- Glaxosmithkline Plc
- Johnson & Johnson
- Keryx Biopharmaceuticals, Inc
- Kissei Pharmaceutical Co., Ltd
- Pfizer, Inc
- Sanofi S.A
- Teva Pharmaceutical Industries Ltd
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Chronic Kidney Disease (Ckd) Drugs Market Analysis
Chapter 4 Global Chronic Kidney Disease (Ckd) Drugs Market, by Drug Class
Chapter 5 Global Chronic Kidney Disease (Ckd) Drugs Market, by Geography
Chapter 6 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/59vgw7/global_chronic